Details

Autor(en) / Beteiligte

• Blanchard-Rohner, Geraldine
• Sanchez, Carlos
• Andre, Maya C.
• Bressieux-Degueldre, Sabrina
• Grazioli, Serge
• Perez, Marie-Helene
• Wütz, Daniela
• Schöbi, Nina
• Welzel, Tatjana
• Atkinson, Andrew
• Schlapbach, Luregn J.
• Bielicki, Julia A.
• Trück, Johannes

Titel

COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children

Ist Teil von

• The Pediatric infectious disease journal, 2024-04, Vol.43 (4), p.361-364

Erscheinungsjahr

2024

Beschreibungen/Notizen

• Data on COVID-19 vaccine acceptability among parents of children with multisystem inflammatory syndrome (MIS-C) are limited. In this cohort of children with MIS-C, enrolled in the Swissped RECOVERY trial (NCT 04826588), comparing intravenous immunoglobulins or methylprednisolone, who, in accordance with Swiss guidelines, were recommended for SARS-CoV-2 vaccination, 65% (73/112) of parents reported being vaccinated against SARS-CoV-2 before the MIS-C, while 70% were vaccinated after the MIS-C episode of their child. None of the children were vaccinated before the occurrence of the MIS-C, and only 9% (5/56) received the COVID-19 vaccine after the MIS-C. The predominant barriers to COVID-19 vaccination were concerns over potential side effects and insufficient support from their doctors. This emphasizes the crucial role of health care providers in promoting COVID-19 vaccination among children.